chr8-90645713-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001008495.4(TMEM64):ā€‹c.193C>Gā€‹(p.Leu65Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000758 in 1,214,424 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000047 ( 0 hom., cov: 32)
Exomes š‘“: 0.000080 ( 0 hom. )

Consequence

TMEM64
NM_001008495.4 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.321
Variant links:
Genes affected
TMEM64 (HGNC:25441): (transmembrane protein 64) Predicted to be involved in negative regulation of canonical Wnt signaling pathway; negative regulation of osteoblast differentiation; and positive regulation of fat cell differentiation. Predicted to act upstream of or within several processes, including positive regulation of bone resorption; positive regulation of osteoclast differentiation; and regulation of ATPase activity. Predicted to be located in endoplasmic reticulum. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.069147736).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TMEM64NM_001008495.4 linkuse as main transcriptc.193C>G p.Leu65Val missense_variant 1/3 ENST00000458549.7 NP_001008495.2 Q6YI46-1
TMEM64NM_001146273.1 linkuse as main transcriptc.193C>G p.Leu65Val missense_variant 1/2 NP_001139745.1 Q6YI46-4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TMEM64ENST00000458549.7 linkuse as main transcriptc.193C>G p.Leu65Val missense_variant 1/31 NM_001008495.4 ENSP00000414786.2 Q6YI46-1

Frequencies

GnomAD3 genomes
AF:
0.0000470
AC:
7
AN:
148850
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000898
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000990
AC:
1
AN:
1010
Hom.:
0
AF XY:
0.00143
AC XY:
1
AN XY:
700
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00136
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000798
AC:
85
AN:
1065464
Hom.:
0
Cov.:
31
AF XY:
0.0000832
AC XY:
42
AN XY:
504882
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000922
Gnomad4 OTH exome
AF:
0.0000237
GnomAD4 genome
AF:
0.0000470
AC:
7
AN:
148960
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
1
AN XY:
72652
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000899
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 04, 2024The c.193C>G (p.L65V) alteration is located in exon 1 (coding exon 1) of the TMEM64 gene. This alteration results from a C to G substitution at nucleotide position 193, causing the leucine (L) at amino acid position 65 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.018
.;T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.49
T;T
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.069
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L;L
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.49
N;N
REVEL
Benign
0.043
Sift
Benign
0.046
D;D
Sift4G
Uncertain
0.049
D;T
Polyphen
0.68
.;P
Vest4
0.12
MutPred
0.13
Gain of catalytic residue at L65 (P = 0.0541);Gain of catalytic residue at L65 (P = 0.0541);
MVP
0.067
MPC
2.9
ClinPred
0.091
T
GERP RS
2.3
Varity_R
0.14
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1041663736; hg19: chr8-91657941; API